-
1
-
-
34548487159
-
Insomnia: Definition, prevalence, etiology, and consequences
-
Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007; 3(suppl):S7-10.
-
(2007)
J Clin Sleep Med
, vol.3
, pp. S7-S10
-
-
Roth, T.1
-
2
-
-
0030823270
-
Prevalence, burden, and treatment of insomnia in primary care
-
Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry. 1997; 154:1417-23.
-
(1997)
Am J Psychiatry
, vol.154
, pp. 1417-1423
-
-
Simon, G.E.1
VonKorff, M.2
-
3
-
-
67349228757
-
Insomnia and its relationship to healthcare utilization, work absenteeism, productivity and accidents
-
Daley M, Morin CM, LeBlanc M et al. Insomnia and its relationship to healthcare utilization, work absenteeism, productivity and accidents. Sleep Med. 2009; 10:427-38.
-
(2009)
Sleep Med
, vol.10
, pp. 427-438
-
-
Daley, M.1
Morin, C.M.2
LeBlanc, M.3
-
4
-
-
79951665856
-
The societal costs of insomnia
-
Wade AG. The societal costs of insomnia. Neuropsychiatr Dis Treat. 2011; 7:1-18.
-
(2011)
Neuropsychiatr Dis Treat
, vol.7
, pp. 1-18
-
-
Wade, A.G.1
-
5
-
-
62349100214
-
The natural history of insomnia: A population-based 3-year longitudinal study
-
Morin CM, Bélanger L, LeBlanc M et al. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med. 2009; 169:447-53.
-
(2009)
Arch Intern Med
, vol.169
, pp. 447-453
-
-
Morin, C.M.1
Bélanger, L.2
LeBlanc, M.3
-
7
-
-
85067747233
-
-
American Psychiatric Association. Highlights to changes from DSM-IV-TR to DSM-5. www.psychiatry.org/File%20Library/Practice/DSM/DSM-5/Changes-from-DSM-IV-TR-to-DSM-5.pdf (accessed 2013 Jun 11).
-
Highlights to Changes from DSM-IV-TR to DSM-5
-
-
-
8
-
-
40749126697
-
Insomnia and comorbid psychiatric disorders
-
Riemann D. Insomnia and comorbid psychiatric disorders. Sleep Med. 2007; 8(suppl 4):S15-20.
-
(2007)
Sleep Med
, vol.8
, pp. S15-S20
-
-
Riemann, D.1
-
9
-
-
65949116784
-
Update on sleep and psychiatric disorders
-
Sateia MJ. Update on sleep and psychiatric disorders. Chest. 2009; 135:1370-9.
-
(2009)
Chest
, vol.135
, pp. 1370-1379
-
-
Sateia, M.J.1
-
12
-
-
39749190543
-
Patterns of quetiapine use in psychiatric inpatients: An examination of off-label use
-
Philip NS, Mello K, Carpenter LL et al. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use. Ann Clin Psychiatry. 2008; 20:15-20.
-
(2008)
Ann Clin Psychiatry
, vol.20
, pp. 15-20
-
-
Philip, N.S.1
Mello, K.2
Carpenter, L.L.3
-
13
-
-
85067769970
-
Quetiapine
-
Greenwood Village, CO: Thomson Reuters (Healthcare). Updated periodically
-
Quetiapine. In: Drugdex System. Greenwood Village, CO: Thomson Reuters (Healthcare). Updated periodically.
-
Drugdex System
-
-
-
14
-
-
62449321971
-
Selective histamine H1 antagonism: Novel hypnotic and pharmacologic actions challenge classical notions of antihistamines
-
Stahl SM. Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines. CNS Spectr. 2008; 13:1027-38.
-
(2008)
CNS Spectr
, vol.13
, pp. 1027-1038
-
-
Stahl, S.M.1
-
15
-
-
55349132739
-
Clinical guideline for the evaluation and management of chronic insomnia in adults
-
Schutte-Rodin S, Broch L, Buysse D et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008; 4:487-504.
-
(2008)
J Clin Sleep Med
, vol.4
, pp. 487-504
-
-
Schutte-Rodin, S.1
Broch, L.2
Buysse, D.3
-
16
-
-
84856402909
-
Guideline, education, and peer comparison to reduce prescriptions of benzodiazepines and low-dose quetiapine in prison
-
Reeves R. Guideline, education, and peer comparison to reduce prescriptions of benzodiazepines and low-dose quetiapine in prison. J Correct Health Care. 2012; 18:45-52.
-
(2012)
J Correct Health Care
, vol.18
, pp. 45-52
-
-
Reeves, R.1
-
19
-
-
11144334174
-
Drugs used to treat insomnia in 2002: Regulatory-based rather than evidence-based medicine
-
Walsh JK. Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine. Sleep. 2004; 27:1441-2.
-
(2004)
Sleep
, vol.27
, pp. 1441-1442
-
-
Walsh, J.K.1
-
20
-
-
85067771255
-
-
Thomson Reuters Micromedex Clinical Evidence Solutions. http://thomsonreuters.com/products-services/healthcare/healthcare-products/clinical-deci-support/micromedex-clinical-evidence-sols/med-safety-solutions/red-book (accessed 2013 Apr 4).
-
-
-
-
21
-
-
1842774440
-
Sleep-promoting properties of quetiapine in healthy subjects
-
Cohrs S, Rodenbeck A, Guan Z et al. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology. 2004; 174:421-9.
-
(2004)
Psychopharmacology
, vol.174
, pp. 421-429
-
-
Cohrs, S.1
Rodenbeck, A.2
Guan, Z.3
-
22
-
-
38349187275
-
Quetiapine in primary insomnia: A pilot study
-
Letter
-
Wiegand MH, Landry F, Brückner T et al. Quetiapine in primary insomnia: a pilot study. Psychopharmacology. 2008; 196:337-8. Letter.
-
(2008)
Psychopharmacology
, vol.196
, pp. 337-338
-
-
Wiegand, M.H.1
Landry, F.2
Brückner, T.3
-
23
-
-
77954527766
-
Quetiapine for primary insomnia: A double blind, randomized controlled trial
-
Tassniyom K, Paholpak S, Tassniyom S et al. Quetiapine for primary insomnia: a double blind, randomized controlled trial. J Med Assoc Thai. 2010; 93:729-34.
-
(2010)
J Med Assoc Thai
, vol.93
, pp. 729-734
-
-
Tassniyom, K.1
Paholpak, S.2
Tassniyom, S.3
-
24
-
-
33746904416
-
Quetiapine augmentation in treatment-resistant depression: A naturalistic study
-
Šagud M, Mihaljević-Peleš A, Mück-Šeler D et al. Quetiapine augmentation in treatment-resistant depression: a naturalistic study. Psychopharmacology. 2006; 187:511-4.
-
(2006)
Psychopharmacology
, vol.187
, pp. 511-514
-
-
Šagud, M.1
Mihaljević-Peleš, A.2
Mück-Šeler, D.3
-
25
-
-
54449093654
-
A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder
-
Garakani A, Martinez JM, Marcus S et al. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. Int Clin Psychopharm. 2008; 23:269-75.
-
(2008)
Int Clin Psychopharm
, vol.23
, pp. 269-275
-
-
Garakani, A.1
Martinez, J.M.2
Marcus, S.3
-
26
-
-
54049124418
-
Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep
-
Endicott J, Paulsson B, Gustafsson U et al. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: improvements in quality of life and quality of sleep. J Affect Disord. 2008; 111:306-19.
-
(2008)
J Affect Disord
, vol.111
, pp. 306-319
-
-
Endicott, J.1
Paulsson, B.2
Gustafsson, U.3
-
27
-
-
77649138108
-
A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)
-
McElroy SL, Weisler RH, Chang W et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry. 2010; 71:163-74.
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 163-174
-
-
McElroy, S.L.1
Weisler, R.H.2
Chang, W.3
-
28
-
-
23644433193
-
Quetiapine for insomnia in Parkinson disease: Results from an open-label trial
-
Juri C, Chaná P, Tapia J et al. Quetiapine for insomnia in Parkinson disease: results from an open-label trial. Clin Neuropharmacol. 2005; 28:185-7.
-
(2005)
Clin Neuropharmacol
, vol.28
, pp. 185-187
-
-
Juri, C.1
Chaná, P.2
Tapia, J.3
-
29
-
-
66749092411
-
Quetiapine for tamoxifen-induced insomnia in women with breast cancer
-
Pasquini M, Speca A, Biondi M. Quetiapine for tamoxifen-induced insomnia in women with breast cancer. Psychosomatics. 2009; 50:159-61.
-
(2009)
Psychosomatics
, vol.50
, pp. 159-161
-
-
Pasquini, M.1
Speca, A.2
Biondi, M.3
-
30
-
-
57649131067
-
Quetiapine in the treatment of sleep disturbances associated with addictive conditions: A retrospective study
-
Terán A, Majadas S, Galan J. Quetiapine in the treatment of sleep disturbances associated with addictive conditions: a retrospective study. Subst Use Misuse. 2008; 43:2169-71.
-
(2008)
Subst Use Misuse
, vol.43
, pp. 2169-2171
-
-
Terán, A.1
Majadas, S.2
Galan, J.3
-
31
-
-
18144390227
-
Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: Comparison of middle-aged and older adults
-
Yamashita H, Mori K, Nagao M et al. Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults. Am J Geriatr Psychiatry. 2005; 13:377-84.
-
(2005)
Am J Geriatr Psychiatry
, vol.13
, pp. 377-384
-
-
Yamashita, H.1
Mori, K.2
Nagao, M.3
-
32
-
-
33751103685
-
Night locomotor activity and quality of sleep in quetiapine-treated patients with depression
-
Todder D, Caliskan S, Baune BT. Night locomotor activity and quality of sleep in quetiapine-treated patients with depression. J Clin Psychopharmacol. 2006; 26:638-42.
-
(2006)
J Clin Psychopharmacol
, vol.26
, pp. 638-642
-
-
Todder, D.1
Caliskan, S.2
Baune, B.T.3
-
33
-
-
33846581048
-
Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression
-
Baune BT, Caliskan S, Todder D. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression. Hum Psychopharmacol Clin Exp. 2007; 22:1-9.
-
(2007)
Hum Psychopharmacol Clin Exp
, vol.22
, pp. 1-9
-
-
Baune, B.T.1
Caliskan, S.2
Todder, D.3
-
34
-
-
68649100415
-
Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients
-
Cates ME, Jackson CW, Feldman JM et al. Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients. Community Ment Health J. 2009; 45:251-4.
-
(2009)
Community Ment Health J
, vol.45
, pp. 251-254
-
-
Cates, M.E.1
Jackson, C.W.2
Feldman, J.M.3
-
35
-
-
51149115322
-
Low-dose quetiapine is not a benign sedative-hypnotic agent
-
Gugger JJ, Cassagnol M. Low-dose quetiapine is not a benign sedative-hypnotic agent. Am J Addict. 2008; 17:454-5.
-
(2008)
Am J Addict
, vol.17
, pp. 454-455
-
-
Gugger, J.J.1
Cassagnol, M.2
-
36
-
-
84860991804
-
Safety of low doses of quetiapine when used for insomnia
-
Coe HV, Hong IS. Safety of low doses of quetiapine when used for insomnia. Ann Pharmacother. 2012; 46:718-22.
-
(2012)
Ann Pharmacother
, vol.46
, pp. 718-722
-
-
Coe, H.V.1
Hong, I.S.2
-
38
-
-
80051966985
-
-
IMS Institute for Healthcare Informatics. The use of medicines in the United States: review of 2011. www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/IHII-Medicines-in-U.S-Report-2011.pdf (accessed 2012 Jun 29).
-
The Use of Medicines in the United States: Review of 2011
-
-
-
39
-
-
77649095652
-
Is Seroquel developing an illicit reputation for misuse/abuse?
-
Sansone RA, Sansone LA. Is Seroquel developing an illicit reputation for misuse/abuse? Psychiatry. 2010; 7:13-6.
-
(2010)
Psychiatry
, vol.7
, pp. 13-16
-
-
Sansone, R.A.1
Sansone, L.A.2
-
40
-
-
33846534295
-
Intravenous quetiapine-cocaine use ("Q-ball")
-
Waters BM, Joshi KG. Intravenous quetiapine-cocaine use ("Q-ball"). Am J Psychiatry. 2007; 164:173-4.
-
(2007)
Am J Psychiatry
, vol.164
, pp. 173-174
-
-
Waters, B.M.1
Joshi, K.G.2
-
42
-
-
80051848902
-
Off-label drug use and promotion: Balancing public health goals and commercial speech
-
Kesselheim AS. Off-label drug use and promotion: balancing public health goals and commercial speech. Am J Law Med. 2011; 37:225-57.
-
(2011)
Am J Law Med
, vol.37
, pp. 225-257
-
-
Kesselheim, A.S.1
|